reference/34983639

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/34983639

Outgoing Links

Predicate	Object
contentType	Journal Article
issn	2072-6694
issueIdentifier	17
pageRange	4107-
publicationName	Cancers
startingPage	4107
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_abb4ba29439f7afca1bdfe82d31f0933 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_e41626dd119568a94e53a653f75c5021 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_a881bc874cdba44d3dfc1e8abbbeace7 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_481c112777eab89917194ac2330f7e5e
bibliographicCitation	Castaño-Díez S, López-Guerra M, Bosch-Castañeda C, Bataller A, Charry P, Esteban D, Guijarro F, Jiménez-Vicente C, Castillo-Girón C, Cortes A, Martínez-Roca A, Triguero A, Álamo JR, Beà S, Costa D, Colomer D, Rozman M, Esteve J, Díaz-Beyá M. Real-World Data on Chronic Myelomonocytic Leukemia: Clinical and Molecular Characteristics, Treatment, Emerging Drugs, and Patient Outcomes. Cancers (Basel). 2022 Aug 25;14(17). PMID: 36077644; PMCID: PMC9455040.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c72b817cf6a7d902c64af32c12c0046a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_348722fa6fe1536ad848777916c4b93e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c11d4766ea097449efa0ae09f8b2e647 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dcd10d83c13f107cea183e02d26658d5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-7486-8484 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-3766-8621 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-9044-4665 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_405ed1167cb9ae9941d04c2152e53be6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_32dd7d7b7b33ffd56ef05055dd7dc5aa http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c63bc0a3431dc93c818d0e9063c1768e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ffac24f823e65a64880560b7c6c4d084 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-5545-0178 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-6260-901X http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-2143-5356 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_96c00cbd00c517cb8c12e77ea10c989b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e2f200898d0d16e2f31a9abf01293e21 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_beab01f7966be4ff50b4bccde8c3dfc6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-6085-2745 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8ee5a208c796a34156e116e0e8fb40eb
date	2022-08-25^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.3390/cancers14174107 https://pubmed.ncbi.nlm.nih.gov/PMC9455040 https://pubmed.ncbi.nlm.nih.gov/36077644
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/37563 https://portal.issn.org/resource/ISSN/2072-6694
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Real-World Data on Chronic Myelomonocytic Leukemia: Clinical and Molecular Characteristics, Treatment, Emerging Drugs, and Patient Outcomes
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9735 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_a03cbeca561fb1c14c97da4488860cbe http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_a22f9b31e8346b70edc21dfcfb8ebdae http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_c7e4d19766b8958e96da36c9f9cf8a76 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_9e97a47eb9e6c78b61149c74e7330d8f http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID28782 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_b1179ffc80d13c0812f905e9c7e285da http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_45bd205c63f9c9cfc7d5ba167cb355f0 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_16730271c45a925ea977059b7793fe70 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9731

Showing number of triples: 1 to 50 of 50.